MTOR and autoimmune disease: Nevertheless, while some immuno-modulatory drugs of the glycolysis/mTOR pathway, such as MMF, methotrexate, and DMF, are used in some autoimmune diseases, many potent glycolysis-inhibitory molecules are still in the pre-clinical phase of study [7].